ImmunityBio获得欧洲药品管理局的条件性市场授权推荐,用于非肌肉侵袭性膀胱癌原位癌的Anktiva®与BCG联合治疗——在欧洲的首次
ImmunityBio获得欧洲药品管理局的条件性市场授权推荐,用于非肌肉侵袭性膀胱癌原位癌的Anktiva®与BCG联合治疗——在欧洲的首次
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.